Caricamento...
Long-term safety, tolerability, and efficacy of fremanezumab in migraine: A randomized study
OBJECTIVE: To assess the long-term safety, tolerability, and efficacy of fremanezumab, a fully humanized monoclonal antibody approved for the preventive treatment of migraine. METHODS: A 52-week, multicenter, randomized, double-blind, parallel-group study evaluated fremanezumab monthly or quarterly...
Salvato in:
| Pubblicato in: | Neurology |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Lippincott Williams & Wilkins
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7682830/ https://ncbi.nlm.nih.gov/pubmed/32913018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000010600 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|